footnote127
Cotinine level outcome based on logistic regression model. Outcome from logrnormal regression model had high attrition and is not included in this report.
Childhood Asthma Prevention Study (CAPS)
Last updated: October 2012
Effects Shown in Research & Outcome Measure Details
Child Health
Outcomes Rated High
144
Childhood Asthma Prevention Study (CAPS)
Show Findings Details
| Outcome Measure | Effect | Follow-up Timing | Sample | Sample Size | Intervention Group | Comparison Group | Group Difference | Effect Size | Statistical Significance | Outcome Type | Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cotinine level | FavorableUnfavorable or ambiguousNo Effect |
12 months | Denver, Colorado sample | 130 children | = 0.66 | = 0.56 | Mean difference = 0.10 | HomeVEE calculated = 0.25 | Not statistically significant, p = 0.28 | Primary | |
| Functional Severity Score | FavorableUnfavorable or ambiguousNo Effect |
12 months | Denver, Colorado sample | 150 children | Mean = 1.03 | Mean = 1.04 | Mean difference = -0.01 | Not available | Not Statistically significant, p = 0.60 | Secondary |
Show Outcome Measure Summary
| Outcome Measure | Outcome Measure Description | Collection Method | Properties | Outcome Type | Operations links |
|---|---|---|---|---|---|
Cotinine level |
The authors measured cotinine levels to detect environmental tobacco smoke exposure. The measure indicates the percentage of infants in whom cotinine levels, a metabolite of nicotine, were greater than 5 nanograms of cotinine per gram of creatinine. | Infant urine samples | Not applicable |
Primary | |
Functional Severity Score |
Incidence and severity of infant respiratory symptoms over the past six months. | Parent/caregiver report | Not applicable |
Secondary |
144
Childhood Asthma Prevention Study (CAPS)
Show Findings Details
| Outcome Measure | Effect | Follow-up Timing | Sample | Sample Size | Intervention Group | Comparison Group | Group Difference | Effect Size | Statistical Significance | Outcome Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Emergency Department Visits | FavorableUnfavorable or ambiguousNo Effect |
Between 24 and 34 months | Denver, CO sample | 144 children | Unadjusted mean 18. 6 = 18.60 | Unadjusted mean = 24.30 | OR = 0.85 | HomeVEE calculated = 0.01 | Not statistically significant, p = .72 | Primary |
| Oral corticosteroid use | FavorableUnfavorable or ambiguousNo Effect |
Between 24 and 34 months | Denver, CO sample | 144 children | Unadjusted mean 18. 6 = 18.60 | Unadjusted mean = 24.30 | OR = 0.69 | HomeVEE calculated = 0.01 | Not statistically significant, p = .44 | Primary |
Show Outcome Measure Summary
| Outcome Measure | Outcome Measure Description | Collection Method | Properties | Outcome Type | Operations links |
|---|---|---|---|---|---|
Emergency Department Visits |
Percentage of child emergency department visits between three and four years of age | Review of medical records | Not applicable |
Primary | |
Oral corticosteroid use |
Percentage of children who had a course of oral corticosteroids during the previous year. | Review of medical records | Not applicable |
Primary |